Clinical comparative study of tegio and apatinib for second-line monotherapy regimens in the treatment of patients with advanced gastric cancer combined with liver metastases

doi:10.3969/j.issn.1672-3384.2019.08.015

NING Ze,CHEN Rui,CHEN Ke-hong,YANG Yong-sheng

Clinical Medication Journal ›› 2019, Vol. 17 ›› Issue (8) : 61-65.

PDF(973 KB)

Clinical Medication Journal ›› 2019, Vol. 17 ›› Issue (8) : 61-65. DOI: 10.3969/j.issn.1672-3384.2019.08.015

Original Paper

Clinical comparative study of tegio and apatinib for second-line monotherapy regimens in the treatment of patients with advanced gastric cancer combined with liver metastases

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2019, 17(8): 61-65 https://doi.org/10.3969/j.issn.1672-3384.2019.08.015

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(973 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2019-01-31	2019-08-30
Issue Date
2019-08-30

Please choose a citation manager

Content to export